NCT00259012View on ClinicalTrials.gov

Study Evaluating Pantoprazole Sodium Enteric-Coated Spheroid Suspension In Infants With Presumed GERD

PHASE3CompletedINTERVENTIONAL
Enrollment

67

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

March 31, 2008

Study Completion Date

March 31, 2008

Conditions
Gastroesophageal Reflux
Interventions
DRUG

pantoprazole sodium enteric-coated spheroid suspension

pediatric suspension taken daily x 7 days

Trial Locations (31)

8032

Zurich

10032

New York

20010

Washington D.C.

25123

Brescia

27710

Durham

32504

Pensacola

33101

Miami

39216

Jackson

40202

Louisville

44106

Cleveland

60068

Park Ridge

60614

Chicago

64108

Kansas City

71130

Shreveport

72205

Little Rock

75674

Paris

76508

Temple

80131

Naples

92103

San Diego

92351

Loma Linda

Unknown

Brisbane

Lublin

B-2020

Antwerp

B-1090

Brussels

B-9000

Ghent

D-52074

Aachen

D-49074

Osnabrück

00161

Roma

30-663

Krakow

91-738

Lodz

04-730

Warsaw

Sponsors

Collaborators (1)

Nycomed
All Listed Sponsors
collaborator

Nycomed

INDUSTRY

lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY